Page last updated: 2024-09-04

disufenton sodium and Hyperglycemia, Postprandial

disufenton sodium has been researched along with Hyperglycemia, Postprandial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dávalos, A; Ferro, JM1
Alderfer, V; Ashwood, T; Davalos, A; Davis, SM; Diener, HC; Grotta, J; HÃ¥rdemark, HG; Lees, KR; Lyden, P; Rodichok, L; Shuaib, A; Wasiewski, W1

Trials

1 trial(s) available for disufenton sodium and Hyperglycemia, Postprandial

ArticleYear
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
    Stroke, 2008, Volume: 39, Issue:6

    Topics: Age Factors; Aged; Antioxidants; Benzenesulfonates; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infarction; Comorbidity; Double-Blind Method; Drug Administration Schedule; Emergency Medical Services; Encephalitis; Female; Humans; Hyperglycemia; Injections, Intravenous; Male; Meta-Analysis as Topic; Middle Aged; Neuroprotective Agents; Placebos; Prognosis; Stroke; Treatment Failure

2008

Other Studies

1 other study(ies) available for disufenton sodium and Hyperglycemia, Postprandial

ArticleYear
Other neuroprotective therapies on trial in acute stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2006, Volume: 21 Suppl 2

    Topics: Anti-Inflammatory Agents; Benzenesulfonates; Drug Combinations; Free Radical Scavengers; Glucose; Hemorrhage; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Interferon beta-1a; Interferon-beta; Neuroprotective Agents; Potassium; Randomized Controlled Trials as Topic; Recombinant Proteins; Stroke; Tissue Plasminogen Activator

2006